Gut bacteria play a pivotal role in obesity’s impact on body fat metabolism

Review explores the complex interplay between gut microbiota dysregulation in obesity and its impacts on white and brown adipose tissue metabolism, focusing on direct and indirect effects on mitochondria, highlighting potential avenues for obesity treatment through microbiota-focused strategies.

More than half of all US adults are eligible for semaglutide therapy

Over 137 million US adults are eligible for semaglutide, driven by expanding indications for diabetes, weight management, and cardiovascular disease prevention.

November 20, 2024

Study of healthy adults over 20+ years reveals daily multivitamin use is not associated with mortality benefit

A recent study published in JAMA Network Open determined the relationship between regular multivitamin (MV) supplementation and mortality risk among United States adults.

June 28, 2024

Biden administration proposes funding bump for FDA, nixing interchangeability requirement

Just days after Congress passed the FDA’s fiscal year 2024 appropriations package at the 11th hour, the Biden administration is asking for a bump in

March 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.